Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Interest & Investment Income (2016 - 2026)

Akebia Therapeutics has reported Interest & Investment Income over the past 10 years, most recently at -$4.8 million for Q4 2025.

  • Quarterly Interest & Investment Income rose 29.81% to -$4.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$24.2 million through Dec 2025, down 32.96% year-over-year, with the annual reading at -$24.2 million for FY2025, 32.96% down from the prior year.
  • Interest & Investment Income was -$4.8 million for Q4 2025 at Akebia Therapeutics, down from -$4.7 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at -$1.4 million in Q3 2023 and troughed at -$7.8 million in Q1 2025.
  • The 5-year median for Interest & Investment Income is -$4.8 million (2021), against an average of -$4.2 million.
  • Year-over-year, Interest & Investment Income skyrocketed 69.16% in 2023 and then crashed 384.98% in 2024.
  • A 5-year view of Interest & Investment Income shows it stood at -$5.1 million in 2021, then skyrocketed by 67.81% to -$1.6 million in 2022, then grew by 13.33% to -$1.4 million in 2023, then tumbled by 384.98% to -$6.9 million in 2024, then grew by 29.81% to -$4.8 million in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Interest & Investment Income are -$4.8 million (Q4 2025), -$4.7 million (Q3 2025), and -$6.8 million (Q2 2025).